MKK4 as oncogene or tumor suppressor: In cancer and senescence, the story's getting old
Open Access
- 10 November 2010
- journal article
- Published by Impact Journals, LLC in Aging
- Vol. 2 (11) , 752-753
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- The Mitogen-Activated Protein Kinase Kinase 4 Has a Pro-Oncogenic Role in Skin CancerCancer Research, 2010
- Increased MKK4 Abundance with Replicative Senescence Is Linked to the Joint Reduction of Multiple MicroRNAsScience Signaling, 2009
- MKK4 Status Predicts Survival After Resection of Gastric AdenocarcinomaArchives of Surgery, 2006
- Targeted Deletion of MKK4 in Cancer Cells: A Detrimental Phenotype Manifests as Decreased Experimental Metastasis and Suggests a Counterweight to the Evolution of Tumor-Suppressor LossCancer Research, 2006
- Theoretical Proposal: Allele Dosage of MAP2K4/MKK4 Could Rationalize Frequent 17p Loss in Diverse Human CancersCell Cycle, 2006
- Mutations in a signalling pathwayNature, 2005
- Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumorsOncogene, 2004
- Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene.1998
- Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.1997